OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SUMOylation in α-Synuclein Homeostasis and Pathology
Mor Savyon, Simone Engelender
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 210

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 115

Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 61

Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology
Magdalena I. Ivanova, Yuxi Lin, Young‐Ho Lee, et al.
Biophysical Chemistry (2020) Vol. 269, pp. 106507-106507
Open Access | Times Cited: 130

Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
Antonella Cardinale, Valeria Calabrese, Antonio de Iure, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6517-6517
Open Access | Times Cited: 53

α-Synuclein in Parkinson's disease and advances in detection
Rong Chen, Xuan Gu, Xiaoying Wang
Clinica Chimica Acta (2022) Vol. 529, pp. 76-86
Closed Access | Times Cited: 33

Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Viviana Brembati, Gaia Faustini, Francesca Longhena, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 18

Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications
Rosie Bell, Michele Vendruscolo
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 34

Posttranslational Modifications ofα-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases
Kambiz Hassanzadeh, Jun Liu, Santhosh Chandar Maddila, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1254-1290
Closed Access | Times Cited: 6

In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease
A. N. R. Da Silva, Gabriel Rodrigues Coutinho Pereira, Luiz Felippe Sarmento Bonet, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 3
Closed Access | Times Cited: 5

Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4

Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases
Y. Wu, Biao Ma, Chang Yu Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10187-10187
Open Access | Times Cited: 4

Second Sphere Interactions in Amyloidogenic Diseases
Madhuparna Roy, Arnab Kumar Nath, Ishita Pal, et al.
Chemical Reviews (2022) Vol. 122, Iss. 14, pp. 12132-12206
Closed Access | Times Cited: 19

SENP2-based N-terminal truncation of α-synuclein in Lewy pathology propagation
Katsutoshi Taguchi, Yoshihisa Watanabe, Masaki Tanaka
iScience (2025) Vol. 28, Iss. 2, pp. 111935-111935
Open Access

Therapeutic Implications and Regulations of Protein Post-translational Modifications in Parkinsons Disease
Twinkle Mishra, Shareen Singh, Thakur Gurjeet Singh
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 2

Targeting α-synuclein post-translational modifications in Parkinson’s disease
Jaquelini Betta Canever, Ericks Sousa Soares, Núbia Carelli Pereira de Avelar, et al.
Behavioural Brain Research (2022) Vol. 439, pp. 114204-114204
Closed Access | Times Cited: 11

Polymorphic USP8 allele promotes Parkinson’s disease by inducing the accumulation of α-synuclein through deubiquitination
Shouhai Wu, Tongxiang Lin, Yang Xu
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 12
Open Access | Times Cited: 5

Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
Frank Y. Shan, Kar‐Ming Fung, Tarek Zieneldien, et al.
Life (2021) Vol. 11, Iss. 11, pp. 1126-1126
Open Access | Times Cited: 7

SUMO2 Protects Against Tau-induced Synaptic and Cognitive Dysfunction
Franca Orsini, Elentina K. Argyrousi, Elena Restelli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3

SUMO modification in Huntington's disease: Unraveling complex mechanisms for therapeutic insights
Charlene Smith, Joan S. Steffan, Leslie M. Thompson
Elsevier eBooks (2024), pp. 259-283
Closed Access

Phosphorylation of α-synuclein fibrils at S129 changes DNAJB1 binding as probed by solid-state NMR
Sayuri Pacheco, Dhanya S. Reselammal, Zhang Qing-ya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1 - Next Page

Scroll to top